Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

2.

Reduced prevalence of hepatitis B surface antigen positivity among pregnant women born after the national implementation of immunoprophylaxis for babies born to hepatitis B virus-carrier mothers in Japan.

Sugiyama A, Ohisa M, Nagashima S, Yamamoto C, Chuon C, Fujii T, Akita T, Katayama K, Kudo Y, Tanaka J.

Hepatol Res. 2017 Nov;47(12):1329-1334. doi: 10.1111/hepr.12943. Epub 2017 Sep 10.

PMID:
28795466
3.

Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).

Karabaev BB, Beisheeva NJ, Satybaldieva AB, Ismailova AD, Pessler F, Akmatov MK.

Infect Dis Poverty. 2017 Feb 21;6(1):45. doi: 10.1186/s40249-017-0255-9.

5.
6.

Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors.

Flichman DM, Blejer JL, Livellara BI, Re VE, Bartoli S, Bustos JA, Ansola CP, Hidalgo S, Cerda ME, Levin AE, Huenul A, Riboldi V, Treviño EM, Salamone HJ, Nuñez FA, Fernández RJ, Reybaud JF, Campos RH.

BMC Infect Dis. 2014 Apr 23;14:218. doi: 10.1186/1471-2334-14-218.

7.

Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.

Wolffram I, Petroff D, Bätz O, Jedrysiak K, Kramer J, Tenckhoff H, Berg T, Wiegand J; German Check-Up 35+ Study Group.

J Hepatol. 2015 Jun;62(6):1256-64. doi: 10.1016/j.jhep.2015.01.011. Epub 2015 Jan 21.

PMID:
25617500
8.

Prevalence of and risk factors for hepatitis B and C infection among Mongolian blood donors.

Tserenpuntsag B, Nelson K, Lamjav O, Triner W, Smith P, Kacica M, McNutt LA.

Transfusion. 2010 Jan;50(1):92-9. doi: 10.1111/j.1537-2995.2009.02387.x. Epub 2009 Sep 25.

PMID:
19788639
9.

Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.

Yano Y, Yamashita F, Sumie S, Ando E, Fukumori K, Kiyama M, Oyama T, Kuroki S, Kato O, Yamamoto H, Tanaka M, Sata M.

Am J Gastroenterol. 2002 Jan;97(1):156-61.

PMID:
11808941
10.

Seroprevalence rates of hepatitis C virus (HCV) antibody and hepatitis B virus surface antigen (HBsAG) in blood donors in a Southwestern Nigerian city.

Motayo BO, Akpa OM, Ezeani I, Faneye AO, Udo UA, Onoja B.

J Immunoassay Immunochem. 2015;36(1):91-9. doi: 10.1080/15321819.2014.899256.

PMID:
24628383
11.

Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh.

Ashraf H, Alam NH, Rothermundt C, Brooks A, Bardhan P, Hossain L, Salam MA, Hassan MS, Beglinger C, Gyr N.

BMC Infect Dis. 2010 Jul 15;10:208. doi: 10.1186/1471-2334-10-208.

12.

Epidemiology of hepatitis B, C and D in Malawi: systematic review.

Stockdale AJ, Mitambo C, Everett D, Geretti AM, Gordon MA.

BMC Infect Dis. 2018 Oct 12;18(1):516. doi: 10.1186/s12879-018-3428-7. Review.

13.

Hepatitis C virus is a more likely cause of chronic liver disease in the Japanese population than hepatitis B virus.

Hayashi J, Hirata M, Nakashima K, Noguchi A, Kashiwagi S, Matsui M, Ishibashi H, Maeda Y.

Fukuoka Igaku Zasshi. 1991 Dec;82(12):648-54.

PMID:
1783356
14.

HBsAg and anti-HCV screening in elderly hospitalized patients of a German tertiary referral centre.

Kant J, Kratzsch J, Maier M, Liebert UG, Berg T, Wiegand J.

Z Gastroenterol. 2016 Mar;54(3):231-7. doi: 10.1055/s-0041-106656. Epub 2016 Apr 4.

PMID:
27043886
15.

One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.

Parry JV, Easterbrook P, Sands AR.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):705. doi: 10.1186/s12879-017-2774-1.

16.

Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus.

de Almeida-Neto C, Sabino EC, Liu J, Blatyta PF, Mendrone-Junior A, Salles NA, Leão SC, Wright DJ, Basques FV, Ferreira JE, Busch MP, Murphy EL; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component.

Transfusion. 2013 Apr;53(4):827-34. doi: 10.1111/j.1537-2995.2012.03840.x. Epub 2012 Aug 6.

17.

Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000.

Tanaka J, Kumagai J, Katayama K, Komiya Y, Mizui M, Yamanaka R, Suzuki K, Miyakawa Y, Yoshizawa H.

Intervirology. 2004;47(1):32-40.

PMID:
15044834
18.

Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.

Hahné SJ, Veldhuijzen IK, Wiessing L, Lim TA, Salminen M, Laar Mv.

BMC Infect Dis. 2013 Apr 18;13:181. doi: 10.1186/1471-2334-13-181. Review.

19.

Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers.

Alzahrani FM, Muzaheed, Shaikh SS, Alomar AI, Acharya S, Elhadi N.

Ann Lab Med. 2019 Jan;39(1):81-85. doi: 10.3343/alm.2019.39.1.81.

20.

Supplemental Content

Support Center